N-亚硝基新烟草碱结构式
|
常用名 | N-亚硝基新烟草碱 | 英文名 | N-nitrosoanabasine |
|---|---|---|---|---|
| CAS号 | 37620-20-5 | 分子量 | 191.230 | |
| 密度 | 1.2±0.1 g/cm3 | 沸点 | 380.2±35.0 °C at 760 mmHg | |
| 分子式 | C10H13N3O | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | 183.8±25.9 °C | |
| 符号 |
GHS06 |
信号词 | Danger |
| 中文名 | N-亚硝基新烟草碱 |
|---|---|
| 英文名 | (r,s)-n-nitrosoanabasine |
| 中文别名 | (R,s)-n-亚硝基新烟草碱 |
| 英文别名 | 更多 |
| 密度 | 1.2±0.1 g/cm3 |
|---|---|
| 沸点 | 380.2±35.0 °C at 760 mmHg |
| 分子式 | C10H13N3O |
| 分子量 | 191.230 |
| 闪点 | 183.8±25.9 °C |
| 精确质量 | 191.105865 |
| PSA | 45.56000 |
| LogP | 0.49 |
| 蒸汽压 | 0.0±0.8 mmHg at 25°C |
| 折射率 | 1.625 |
| 储存条件 | -20°C Freezer |
|
~%
N-亚硝基新烟草碱 37620-20-5 |
| 文献：Chemische Berichte, , vol. 65, p. 1126,1128 |
|
~%
N-亚硝基新烟草碱 37620-20-5 |
| 文献：Chemische Berichte, , vol. 65, p. 1126,1128 |
| N-亚硝基新烟草碱上游产品 2 | |
|---|---|
| N-亚硝基新烟草碱下游产品 0 | |
| 海关编码 | 2933990090 |
|---|---|
| 中文概述 | 2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期 |
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Pancreatic endoplasmic reticulum kinase activation promotes medulloblastoma cell migration and invasion through induction of vascular endothelial growth factor A.
PLoS ONE 10(3) , e0120252, (2015) Evidence is accumulating that activation of the pancreatic endoplasmic reticulum kinase (PERK) in response to endoplasmic reticulum (ER) stress adapts tumor cells to the tumor microenvironment and enh... |
|
|
Physiologically based pharmacokinetic modeling to predict drug-drug interactions involving inhibitory metabolite: a case study of amiodarone.
Drug Metab. Dispos. 43(2) , 182-9, (2014) Evaluation of drug-drug interaction (DDI) involving circulating inhibitory metabolites of perpetrator drugs has recently drawn more attention from regulatory agencies and pharmaceutical companies. Her... |
|
|
Disparities in child mortality trends: what is the evidence from disadvantaged states in India? the case of Orissa and Madhya Pradesh.
Int J Equity Health 12 , 45, (2013) The Millennium Development Goals prompted renewed international efforts to reduce under-five mortality and measure national progress. However, scant evidence exists about the distribution of child mor... |
| 3-(1-Nitrosopiperidin-2-yl)pyridine |
| 1-nitro-pyrene |
| Pyrene,1-nitro |
| Nitropyrene,Mono-,Di-,Tri-Tetra,isomers |
| 3-Nitropyrene |
| nitropyrene |
| 1-nitropyrne |
| 3-(1-Nitroso-2-piperidinyl)pyridine |
| N-nitrosoanabasine |
| 1-nitroso-anabasine |
| Pyridine, 3-(1-nitroso-2-piperidinyl)- |
| Nitrosoanabasin |
